Page 111 - GPD-3-2
P. 111

Gene & Protein in Disease                                                   Inhibition of SOD1 in diseases



            Funding                                               doi: 10.1038/nrneurol.2011.150

            None.                                              5.   Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/
                                                                  Zn superoxide dismutase gene are associated with familial
            Conflict of interest                                  amyotrophic lateral sclerosis. Nature. 1993;362(6415):59-62.

            No conflicts of interest to declare.                  doi: 10.1038/362059a0
                                                               6.   Sibilla C, Bertolotti A. Prion properties of SOD1 in
            Author contributions                                  amyotrophic  lateral  sclerosis  and potential  therapy.  Cold

            Conceptualization: Ayodele Sunday Alonge, Toluwase    Spring Harbor Perspect Biol. 2017;9(10):a024141.
               Hezekiah Fatoki, Iseoluwa Isaac Ajayi              doi: 10.1101/cshperspect.a024141
            Format analysis:  Ayodele Sunday Alonge, Toluwase   7.   Ligon LA, LaMonte BH, Wallace KE, Weber N, Kalb RG,
               Hezekiah Fatoki, Iseoluwa Isaac Ajayi, Courage Dele   Holzbaur EL. Mutant superoxide dismutase disrupts
               Famusiwa, Oluwafijimi Adetuyi                      cytoplasmic dynein in motor neurons.  Neuroreport.
            Investigation: Ayodele Sunday Alonge, Toluwase Hezekiah   2005;16(6):533-536.
               Fatoki, Iseoluwa Isaac Ajayi, Ibrahim Olabayode Saliu,      doi: 10.1097/00001756-200504250-00002
               Stanley Chukwuejim, Ohunene Esther Joseph
            Methodology:  Toluwase Hezekiah Fatoki, Ibrahim    8.   Zhang F, Strom AL, Fukada K, Lee S, Hayward LJ, Zhu H.
               Olabayode Saliu                                    Interaction  between  familial  amyotrophic  lateral  sclerosis
            Writing – original draft: Ayodele Sunday Alonge, Toluwase   (ALS)-linked SOD1 mutants and the dynein complex. J Biol
               Hezekiah Fatoki, Iseoluwa Isaac Ajayi, Courage Dele   Chem. 2007;282(22):16691-16699.
               Famusiwa, Ohunene Esther Joseph                    doi: 10.1074/jbc.M609743200
            Writing – review & drafting:  Ayodele Sunday  Alonge,   9.   Elchuri S, Oberley TD, Qi W,  et al. CuZnSOD deficiency
               Toluwase Hezekiah Fatoki, Stanley Chukwuejim,      leads to persistent and widespread oxidative damage and
               Oluwafijimi Adetuyi                                hepatocarcinogenesis later in life. Oncogene. 2005;24(3):367-380.

            Ethics approval and consent to participate            doi: 10.1038/sj.onc.1208207
                                                               10.  Busuttil RA, Garcia AM, Cabrera C,  et al. Organ-specific
            Not applicable.
                                                                  increase in mutation accumulation and apoptosis rate in
            Consent for publication                               CuZn-superoxide dismutase-deficient mice.  Cancer Res.
                                                                  2005;65(24):11271-11275.
            Not applicable.                                       doi: 10.1158/0008-5472.CAN-05-2980

            Availability of data                               11.  Ho YS, Gargano M, Cao J, Bronson RT, Heimler I, Hutz  RJ.
                                                                  Reduced fertility in female mice lacking copper-zinc
            Data used in this study are available on request from the   superoxide dismutase. J Biol Chem. 1998;273(13):7765-7769.
            corresponding author.
                                                                  doi: 10.1074/jbc.273.13.7765
            References                                         12.  Blander G, De Oliveira RM, Conboy CM, Haigis M,
            1.   Fridovich I. Superoxide radical and superoxide dismutases.   Guarente   L. Superoxide dismutase 1 knock-down
               Annu Rev Biochem. 1995;64:97-112.                  induces senescence in human fibroblasts.  J  Biol Chem.
                                                                  2003;278(40):38966-38969.
               doi: 10.1146/annurev.bi.64.070195.000525
                                                                  doi: 10.1074/jbc.M307146200
            2.   Juarez  JC,  Manuia  M,  Burnett  ME,  et al.  Superoxide
               dismutase 1 (SOD1) is essential for H O -mediated oxidation   13.  Somwar  R,  Erdjument-Bromage  H,  Larsson  E,  et  al.
                                           2
                                         2
               and inactivation of phosphatases in growth factor signaling.   Superoxide  dismutase 1  (SOD1) is a target  for a small
               Proc Natl Acad Sci U S A. 2008;105(20):7147-7152.  molecule identified in a screen for inhibitors of the growth
                                                                  of lung adenocarcinoma cell lines. Proc Natl Acad Sci U S A.
               doi: 10.1073/pnas.0709451105                       2011;108(39):16375-16380.
            3.   Ticozzi N, Tiloca C, Morelli C,  et al. Genetics of familial      doi: 10.1073/pnas.1113554108
               amyotrophic lateral sclerosis. Arch Ital Biol. 2011;149(1):65-82.
                                                               14.  Szklarczyk D, Gable AL, Nastou KC,  et al.  The STRING
               doi: 10.4449/aib.v149i1.1262
                                                                  database  in  2021:  Customizable  protein-protein
            4.   Andersen PM, Al-Chalabi A. Clinical genetics of   networks,  and  functional  characterization  of  user-
               amyotrophic lateral sclerosis: What do we really know? Nat   uploaded gene/measurement sets.  Nucleic Acids Res.
               Rev Neurol. 2011;7(11):603-615.                    2021;49(D1):D605-D612.


            Volume 3 Issue 2 (2024)                         10                              doi: 10.36922/gpd.3042
   106   107   108   109   110   111   112   113   114   115   116